학술논문

EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 2,035건 | 목록 1~20
Reference
Benezit Dictionary of Artists, 2011
Academic Journal
Hueso T; Early Drug Development Department, Gustave Roussy, F-94805 Villejuif, France.; Department of Clinical Hematology, Gustave Roussy, F-94805 Villejuif, France.; Cagnat J; Early Drug Development Department, Gustave Roussy, F-94805 Villejuif, France.; Ouali K; Early Drug Development Department, Gustave Roussy, F-94805 Villejuif, France.; Haberstich M; Early Drug Development Department, Gustave Roussy, F-94805 Villejuif, France.; Henry B; Department of Infectious Disease, Kremlin Bicêtre Hospital (AP-HP), F-94275 Kremlin-Bicêtre, France.; Danu A; Department of Clinical Hematology, Gustave Roussy, F-94805 Villejuif, France.; Bigenwald C; Department of Clinical Hematology, Gustave Roussy, F-94805 Villejuif, France.; Merad M; Department of Medical Emergency, Gustave Roussy, F-94805 Villejuif, France.; Messayke S; Pharmacovigilance Unit, Clinical Research Direction, Gustave Roussy, F-94805 Villejuif, France.; Laparra A; Early Drug Development Department, Gustave Roussy, F-94805 Villejuif, France.; Sakkal M; Early Drug Development Department, Gustave Roussy, F-94805 Villejuif, France.; Smolenschi C; Early Drug Development Department, Gustave Roussy, F-94805 Villejuif, France.; Hollebecque A; Early Drug Development Department, Gustave Roussy, F-94805 Villejuif, France.; Gazzah A; Early Drug Development Department, Gustave Roussy, F-94805 Villejuif, France.; Baldini C; Early Drug Development Department, Gustave Roussy, F-94805 Villejuif, France.; Bahleda R; Early Drug Development Department, Gustave Roussy, F-94805 Villejuif, France.; Besse B; Department of Medical Oncology, Gustave Roussy, F-94805 Villejuif, France.; Paris-Saclay University.; Rigaud C; Department of Pediatric Cancer, Gustave Roussy, F-94805 Villejuif, France.; Minard-Colin V; Department of Pediatric Cancer, Gustave Roussy, F-94805 Villejuif, France.; Paris-Saclay University.; Ribrag V; Early Drug Development Department, Gustave Roussy, F-94805 Villejuif, France.; Department of Clinical Hematology, Gustave Roussy, F-94805 Villejuif, France.; Laghouati S; Pharmacovigilance Unit, Clinical Research Direction, Gustave Roussy, F-94805 Villejuif, France.; Chachaty E; Department of Microbiology, Gustave Roussy, F-94805 Villejuif, France.; Barlesi F; Department of Medical Oncology, Gustave Roussy, F-94805 Villejuif, France.; Paris-Saclay University.; Marabelle A; Early Drug Development Department, Gustave Roussy, F-94805 Villejuif, France.; Paris-Saclay University.; Lambotte O; Department of Internal Medicine and Clinical Immunology, Kremlin-Bicêtre Hospital (AP-HP), UMR1184 IMVA-HB, IDMIT, CEA, INSERM, le Kremlin-Bicêtre, France.; Paris-Saclay University.; Massard C; Early Drug Development Department, Gustave Roussy, F-94805 Villejuif, France.; Paris-Saclay University.; Michot JM; Early Drug Development Department, Gustave Roussy, F-94805 Villejuif, France.; Department of Clinical Hematology, Gustave Roussy, F-94805 Villejuif, France.
Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE
Academic Journal
Goyal L; Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, USA; Department of Medicine, Stanford Cancer Center, Stanford University School of Medicine, Palo Alto, USA. Electronic address: lgoyal@stanford.edu.; DiToro D; Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, USA.; Facchinetti F; Université Paris-Saclay, Gustave Roussy, Inserm U981, Villejuif, France.; Martin EE; Broad Institute of Harvard and MIT, Cambridge, USA.; Peng P; TransThera Sciences (Nanjing), Inc., Nanjing, China.; Baiev I; Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, USA.; Iyer R; Department of Medical Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, USA.; Maurer J; Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, USA.; Reyes S; Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, USA.; Zhang K; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA.; Majeed U; Division of Hematology/Oncology, Mayo Clinic, Jacksonville, USA.; Berchuck JE; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA.; Chen CT; Department of Medicine, Stanford Cancer Center, Stanford University School of Medicine, Palo Alto, USA.; Walmsley C; Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, USA.; Pinto C; Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, USA.; Vasseur D; Université Paris-Saclay, Gustave Roussy, Inserm U981, Villejuif, France.; Gordan JD; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA.; Mody K; Division of Hematology/Oncology, Mayo Clinic, Jacksonville, USA.; Borad M; Division of Hematology/Oncology, Mayo Clinic, Scottsdale, USA.; Karasic T; Department of Medicine, University of Pennsylvania Abramson Cancer Center, Philadelphia, USA.; Damjanov N; Department of Medicine, University of Pennsylvania Abramson Cancer Center, Philadelphia, USA.; Danysh BP; Broad Institute of Harvard and MIT, Cambridge, USA.; Wehrenberg-Klee E; Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, USA.; Kambadakone AR; Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, USA.; Saha SK; Human Biology Division, Fred Hutchinson Cancer Center, Seattle, USA.; Hoffman ID; Tyra Biosciences, San Diego, USA.; Nelson KJ; Tyra Biosciences, San Diego, USA.; Iyer S; Tyra Biosciences, San Diego, USA.; Qiang X; TransThera Sciences (Nanjing), Inc., Nanjing, China.; Sun C; TransThera Sciences (Nanjing), Inc., Nanjing, China.; Wang H; TransThera Sciences (Nanjing), Inc., Nanjing, China.; Li L; TransThera Sciences (Nanjing), Inc., Nanjing, China.; Javle M; MD Anderson Cancer Center, Houston, USA.; Lin B; Virginia Mason Medical Center, Seattle, USA.; Harris W; Department of Medicine, University of Washington/Fred Hutchinson Cancer Center, Seattle, USA.; Zhu AX; Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, USA.; Cleary JM; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA.; Flaherty KT; Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, USA.; Harris T; Tyra Biosciences, San Diego, USA.; Shroff RT; Department of Medicine, University of Arizona Cancer Center, University of Arizona, Tucson, USA.; Leshchiner I; Broad Institute of Harvard and MIT, Cambridge, USA.; Parida L; IBM Research, Yorktown Heights, USA.; Kelley RK; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA.; Fan J; TransThera Sciences (US), Inc., Gaithersburg, USA.; Stone JR; Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, USA.; Uboha NV; Department of Medicine, University of Wisconsin Carbone Cancer Center, Madison, WI, USA.; Hirai H; Tsukuba Research Institute, Taiho Pharmaceutical Co., Ltd., Japan.; Sootome H; Tsukuba Research Institute, Taiho Pharmaceutical Co., Ltd., Japan.; Wu F; TransThera Sciences (Nanjing), Inc., Nanjing, China.; Bensen DC; Tyra Biosciences, San Diego, USA.; Hollebecque A; Université Paris-Saclay, Gustave Roussy, Inserm U981, Villejuif, France.; Friboulet L; Université Paris-Saclay, Gustave Roussy, Inserm U981, Villejuif, France.; Lennerz JK; Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, USA.; Getz G; Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, USA; Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, USA; Broad Institute of Harvard and MIT, Cambridge, USA.; Juric D; Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, USA.
Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE
Academic Journal
Papakonstantinou D; Gustave Roussy Cancer Campus, INSERM U1015, Villejuif, France.; Wang H; Gustave Roussy Cancer Campus, CNRS UMR9018, Villejuif, France.; Bani MA; Gustave Roussy Cancer Campus, Medical oncology department, Villejuif, France.; Mulder K; Gustave Roussy Cancer Campus, INSERM U1015, Villejuif, France.; Dunsmore G; Gustave Roussy Cancer Campus, INSERM U1015, Villejuif, France.; Boilève A; Gustave Roussy Cancer Campus, INSERM U1279, Université Paris Saclay, Villejuif, France; Gustave Roussy Cancer Campus, Biopathology department, Villejuif, France.; Jules-Clément G; Gustave Roussy Cancer Campus, Bioinformatics Core Facility, CNRS, INSERM, Université Paris-Saclay, Villejuif, France.; Panunzi L; Gustave Roussy Cancer Campus, INSERM U981, Université Paris Saclay, Villejuif, France.; de Sousa LR; Gustave Roussy Cancer Campus, INSERM U1015, Villejuif, France.; de la Calle Fabregat C; Gustave Roussy Cancer Campus, INSERM U1015, Villejuif, France.; Deloger M; Gustave Roussy Cancer Campus, Bioinformatics Core Facility, CNRS, INSERM, Université Paris-Saclay, Villejuif, France.; Signolle N; Gustave Roussy Cancer Campus, Biopathology department, Villejuif, France.; Gessain G; Gustave Roussy Cancer Campus, Biopathology department, Villejuif, France.; Nikolaev SI; Gustave Roussy Cancer Campus, INSERM U981, Université Paris Saclay, Villejuif, France.; Ducreux M; Gustave Roussy Cancer Campus, Medical oncology department, Villejuif, France.; Hollebecque A; Gustave Roussy Cancer Campus, Medical oncology department, Villejuif, France.; Ginhoux F; Gustave Roussy Cancer Campus, INSERM U1015, Villejuif, France.; Blériot C; Gustave Roussy Cancer Campus, INSERM U1015, Villejuif, France; Gustave Roussy Cancer Campus, CNRS UMR9018, Villejuif, France; Institut Necker Enfants Malades, CNRS, INSERM, Université Paris Cité, Paris, France. Electronic address: camille.bleriot@cnrs.fr.
Publisher: Elsevier Country of Publication: England NLM ID: 101694651 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2468-2942 (Electronic) Linking ISSN: 24682942 NLM ISO Abbreviation: Cancer Treat Res Commun Subsets: MEDLINE
Academic Journal
Boilève A; Gustave Roussy, Département de Médecine Oncologique, 94805 Villejuif, France.; Université Paris-Saclay, 91400 Orsay, France.; Gustave Roussy, Unité INSERM U1279, 94805 Villejuif, France.; Smolenschi C; Gustave Roussy, Département de Médecine Oncologique, 94805 Villejuif, France.; Gustave Roussy, Département d'Innovation Thérapeutiques et d'Essais Précoces, 94805 Villejuif, France.; Lambert A; Institut de Cancérologie de Lorraine, INSERM, INSPIIRE, Université de Lorraine, 54052 Nancy, France.; Boige V; Gustave Roussy, Département de Médecine Oncologique, 94805 Villejuif, France.; Delaye M; Gustave Roussy, Département de Médecine Oncologique, 94805 Villejuif, France.; Camilleri GM; Gustave Roussy, Département de Médecine Oncologique, 94805 Villejuif, France.; Tarabay A; Gustave Roussy, Département de Médecine Oncologique, 94805 Villejuif, France.; Valéry M; Gustave Roussy, Département de Médecine Oncologique, 94805 Villejuif, France.; Fuerea A; Gustave Roussy, Département de Médecine Oncologique, 94805 Villejuif, France.; Pudlarz T; Gustave Roussy, Département de Médecine Oncologique, 94805 Villejuif, France.; Mathieu JRR; Université Paris-Saclay, 91400 Orsay, France.; Gustave Roussy, Unité INSERM U1279, 94805 Villejuif, France.; Jaulin F; Université Paris-Saclay, 91400 Orsay, France.; Gustave Roussy, Unité INSERM U1279, 94805 Villejuif, France.; Hollebecque A; Gustave Roussy, Département de Médecine Oncologique, 94805 Villejuif, France.; Gustave Roussy, Département d'Innovation Thérapeutiques et d'Essais Précoces, 94805 Villejuif, France.; Ducreux M; Gustave Roussy, Département de Médecine Oncologique, 94805 Villejuif, France.; Université Paris-Saclay, 91400 Orsay, France.
Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE
Academic Journal
Vasseur D; Medical Biology and Pathology Department, Gustave Roussy, Villejuif, France.; AMMICa UAR3655/US23, Gustave Roussy, Villejuif, France.; Bigot L; Université Paris-Saclay, Gustave Roussy, Inserm U981, Villejuif, France.; Beshiri K; Département d'Innovation Thérapeutique (DITEP), Gustave Roussy, Villejuif, France.; Flórez-Arango J; Université Paris-Saclay, Gustave Roussy, Inserm U981, Villejuif, France.; Facchinetti F; Université Paris-Saclay, Gustave Roussy, Inserm U981, Villejuif, France.; Hollebecque A; Département d'Innovation Thérapeutique (DITEP), Gustave Roussy, Villejuif, France.; Département de Médecine Oncologique, Gustave Roussy, Villejuif, France.; Tselikas L; Department of Interventional Radiology, BIOTHERIS, Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Aldea M; Département de Médecine Oncologique, Gustave Roussy, Villejuif, France.; Blanc-Durand F; Département de Médecine Oncologique, Gustave Roussy, Villejuif, France.; Gazzah A; Département d'Innovation Thérapeutique (DITEP), Gustave Roussy, Villejuif, France.; Planchard D; Département de Médecine Oncologique, Gustave Roussy, Villejuif, France.; Lacroix L; Medical Biology and Pathology Department, Gustave Roussy, Villejuif, France.; AMMICa UAR3655/US23, Gustave Roussy, Villejuif, France.; Pata-Merci N; AMMICa UAR3655/US23, Gustave Roussy, Villejuif, France.; Nobre C; Université Paris-Saclay, Gustave Roussy, Inserm U981, Villejuif, France.; Da Silva A; Université Paris-Saclay, Gustave Roussy, Inserm U981, Villejuif, France.; Nicotra C; Département d'Innovation Thérapeutique (DITEP), Gustave Roussy, Villejuif, France.; Ngo-Camus M; Département d'Innovation Thérapeutique (DITEP), Gustave Roussy, Villejuif, France.; Braye F; Université Paris-Saclay, Gustave Roussy, Inserm U981, Villejuif, France.; Nikolaev SI; Université Paris-Saclay, Gustave Roussy, Inserm U981, Villejuif, France.; Michiels S; Université Paris-Saclay, CESP, InsermVillejuif, France.; Office of Biostatistics and Epidemiology, Gustave Roussy, Villejuif, France.; Jules-Clement G; Bioinformatics Core Facility, Gustave Roussy, Université Paris-Saclay, CNRS UMS 3655, Inserm US23, Villejuif, France.; Olaussen KA; Université Paris-Saclay, Gustave Roussy, Inserm U981, Villejuif, France.; André F; Université Paris-Saclay, Gustave Roussy, Inserm U981, Villejuif, France.; Département de Médecine Oncologique, Gustave Roussy, Villejuif, France.; Scoazec JY; Medical Biology and Pathology Department, Gustave Roussy, Villejuif, France.; AMMICa UAR3655/US23, Gustave Roussy, Villejuif, France.; Barlesi F; Département de Médecine Oncologique, Gustave Roussy, Villejuif, France.; Ponce S; Université Paris-Saclay, Gustave Roussy, Inserm U981, Villejuif, France.; Département de Médecine Oncologique, Gustave Roussy, Villejuif, France.; Soria JC; Université Paris-Saclay, Gustave Roussy, Inserm U981, Villejuif, France.; Département de Médecine Oncologique, Gustave Roussy, Villejuif, France.; Besse B; Université Paris-Saclay, Gustave Roussy, Inserm U981, Villejuif, France.; Département de Médecine Oncologique, Gustave Roussy, Villejuif, France.; Loriot Y; Université Paris-Saclay, Gustave Roussy, Inserm U981, Villejuif, France. yohann.loriot@gustaveroussy.fr.; Département d'Innovation Thérapeutique (DITEP), Gustave Roussy, Villejuif, France. yohann.loriot@gustaveroussy.fr.; Département de Médecine Oncologique, Gustave Roussy, Villejuif, France. yohann.loriot@gustaveroussy.fr.; Friboulet L; Université Paris-Saclay, Gustave Roussy, Inserm U981, Villejuif, France. luc.friboulet@gustaveroussy.fr.
Publisher: BioMed Central Country of Publication: England NLM ID: 101147698 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-4598 (Electronic) Linking ISSN: 14764598 NLM ISO Abbreviation: Mol Cancer Subsets: MEDLINE
Academic Journal
Lebeaud A; Department of Medical Oncology, CHU Lille, Lille, France.; Antoun L; Gustave Roussy Cancer Campus, Villejuif, France.; Paccard JR; Department of Medical Oncology and Hepatogastroenterology, Lyon University Hospital Center, Hospices Civiles de Lyon, Lyon, France.; Edeline J; Department of Medical Oncology, Centre Eugène Marquis, Rennes, France.; Bourien H; Department of Medical Oncology, Centre Eugène Marquis, Rennes, France.; Fares N; Department of Digestive Oncology, Centre Hospitalier Universitaire de Toulouse, Hôpital Rangueil, Toulouse, France.; Tournigand C; Department of Medical Oncology, Centre Hospitalier Universitaire Henri-Mondor, AP-HP, Creteil, France.; Lecomte T; Department of Gastroenterology, CHU de Tours, Hôpital Trousseau, Chambray-lès-Tours, France.; Tougeron D; Department of Gastroenterology and Hepatology, CHU Poitiers, Hôpital Jean Bernard, Poitiers, France.; Hautefeuille V; Department of Gastroenterology, Digestive Oncology Department, CHU Amiens-Picardie - Site Nord, Amiens, France.; Viénot A; Department of Medical Oncology, CHU Besancon, Hôpital Jean Minjoz, Besançon, France.; Henriques J; University of Franche-Comté, EFS, INSERM, UMR RIGHT, Besançon, France.; Methodology and Quality of Life Unit in Oncology, CHU Besançon, Besançon, France.; Williet N; Department of Hepatogastroenterology, University Hospital of Saint-Etienne, Saint-Etienne, France.; Bachet JB; Department of Hepato-Gastroenterology and Digestive Oncology, Groupe Hospitalier Pitié Salpetriere, Paris, France.; Smolenschi C; Drug Development Department (DITEP), Gustave Roussy Cancer Campus, Villejuif, France.; Hollebecque A; Drug Development Department (DITEP), Gustave Roussy Cancer Campus, Villejuif, France.; Macarulla T; Department of Gastrointestinal and Endocrine Tumor, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Castet F; Department of Gastrointestinal and Endocrine Tumor, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Malka D; Department of Medical Oncology, Institut Mutualiste Montsouris, Paris, France.; Neuzillet C; Department of GI Oncology, Medical Oncology, Curie Institute, Paris, France.; Vernerey D; University of Franche-Comté, EFS, INSERM, UMR RIGHT, Besançon, France.; Methodology and Quality of Life Unit in Oncology, CHU Besançon, Besançon, France.; Boilève A; Department of Medical Oncology, Gustave Roussy, Villejuif, France.; Turpin A; Department of Medical Oncology, CHU Lille, Lille, France.; CNRS INSERM UMR9020-U1277, CANTHER Cancer Heterogeneity Plasticity and Resistance to Therapies, Université de Lille, Lille, France.; GERCOR, Paris, France.
Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 101160857 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1478-3231 (Electronic) Linking ISSN: 14783223 NLM ISO Abbreviation: Liver Int Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Hollebecque, A.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어